What Central Retinal Artery Occlusion Is and Typical Symptoms
Central retinal artery occlusion is an acute vascular condition occurring when the main artery supplying oxygen and nutrients to the retina becomes blocked. Because retinal cells depend on continuous blood flow, arterial obstruction causes rapid retinal ischaemia. Clinically considered an ocular stroke, it shares underlying vascular causes with cerebral strokes.
The hallmark symptom is sudden, severe loss of vision in one eye, developing in seconds without physical pain. Some individuals experience brief temporary vision loss, termed amaurosis fugax, in preceding days. An ophthalmic examination typically reveals a pale, oedematous retina with a characteristic cherry-red spot at the macula, where choroidal circulation shows through the thinned retinal centre.
Blockages usually arise from emboli dislodged from carotid plaques or cardiac clots, and less often from local thrombosis or temporal arteritis.
How Central Retinal Artery Occlusion Is Diagnosed
Diagnosing central retinal artery occlusion requires immediate ocular evaluations and comprehensive vascular investigations. Hospitals in Turkey utilise advanced imaging to evaluate retinal damage and locate embolic sources. Patients travelling for post-acute assessments should bring prior visual acuity records, retinal photos, hospital summaries, and vascular scans.
Key diagnostic investigations include:
- Optical coherence tomography: Scans showing inner retinal thickening and swelling acutely, followed by layer thinning in chronic stages.
- Fundus fluorescein angiography: An intravenous dye test demonstrating delayed arterial filling in the retinal vascular bed.
- Carotid Doppler ultrasound: Assesses neck arteries for narrowing, ulcerated plaques, or stenosis shedding emboli.
- Echocardiography: Transthoracic or transoesophageal heart scans checking for cardiac thrombi, valve vegetations, or patent foramen ovale.
- Systemic blood panels: Conducted via hospital Check-ups & Diagnostics departments to exclude temporal arteritis and assess lipid and glucose levels.
Treatment Options and Clinical Approaches
Therapy focuses on acute emergency measures and long-term secondary prevention. Because retinal tissue suffers irreversible injury within hours of complete ischaemia, visual recovery is often limited. Clinical management prioritises preventing future vascular events in the brain and heart, alongside monitoring the eye for secondary complications. The treating physician determines appropriate care after reviewing all diagnostic findings.
| Option |
Typically used when |
Things to know |
| Acute conservative measures |
Applied during early hours in emergency care |
Ocular massage and pressure-lowering medications attempt to dislodge emboli, though clinical efficacy varies. |
| Hyperbaric oxygen therapy |
Selected patients presenting in early timeframes |
Breathing pure oxygen in a pressurised chamber aims to increase oxygen diffusion into ischaemic retinal tissue. |
| Secondary stroke prevention |
All confirmed cases following initial stabilisation |
Involves daily antiplatelet or anticoagulant drugs, statins, and blood pressure control to reduce cardiovascular risks. |
| Vascular and cardiac interventions |
Identified severe carotid stenosis or cardiac emboli |
Procedures such as carotid stenting or surgery coordinated through Neurosurgery or Cardiac Surgery teams. |
| Ocular surveillance and laser care |
Monitoring for abnormal vessel proliferation |
Surveillance through Eye Surgery units to manage neovascular complications using anti-VEGF injections or photocoagulation. |
Planning Treatment in Turkey
Medical travel for central retinal artery occlusion is suitable solely for post-acute secondary prevention, comprehensive vascular diagnostics, and long-term planning. Because an acute blockage is a medical emergency requiring instant attention, patients must seek emergency care locally rather than travelling abroad.
When planning a post-stabilisation assessment in Turkey, patients should follow several practical steps:
- Medical dossier review: Patients submit ophthalmic notes, OCT scans, and medical histories in advance so Turkish clinical teams can organise coordinated consultations between ophthalmologists, cardiologists, and neurologists.
- Metabolic assessment: Patients with concurrent metabolic disorders often receive integrated care from Endocrinology specialists to address systemic vascular risk factors.
- Duration of stay: An in-depth evaluation typically requires three to five days in Turkey to complete cardiac monitoring, carotid imaging, and multidisciplinary reviews.
- Follow-up planning: Before leaving, patients receive full documentation, digital scans, and therapy plans to share with their home physicians for continued care.
When Travel Is Not Advisable and Urgent Warning Signs
Patients must not travel if vision loss occurred within the past forty-eight hours. Immediate local emergency assessment is necessary to manage stroke risks and initiate time-critical measures. Delaying evaluation to travel creates severe risks to life and vision.
Furthermore, international travel should be postponed if any of the following warning signs occur:
- New neurological symptoms: Facial droop, speech difficulties, limb weakness, numbness, or ataxia indicating active cerebral ischaemia.
- Signs of temporal arteritis: Severe new headaches, scalp tenderness, jaw pain while eating, or vision changes in the fellow eye requiring prompt steroid therapy.
- Eye pain or redness: Discomfort suggesting elevated intraocular pressure or secondary neovascular glaucoma.
- Unstable cardiac symptoms: Chest tightness, palpitations, or breathlessness suggesting acute cardiovascular instability.
